Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 2Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 4Pain, Postoperative 2Vesico-Ureteral Reflux 1Uterine Neoplasms 1Ureteral Neoplasms 1Peritoneal Cancer 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neuralgia 1Nephrolithiasis 1Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Leiomyoma 1Kidney Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Digestive System Diseases 1Breast Cancer Female 1Abdominal Cancer 1

Interventions

Carboplatin 67Cisplatin 57Paclitaxel 42Radiotherapy 35Pemetrexed 34Gemcitabine 31Docetaxel 31Etoposide 25pembrolizumab 21Vinorelbine 20Erlotinib Hydrochloride 13Magnetic Resonance Spectroscopy 12Gefitinib 11Specimen Handling 10Radiosurgery 10Drug Therapy 10Bevacizumab 10durvalumab 9Nivolumab 9Vinblastine 6Topotecan 6Surgical Procedures, Operative 6Cyclophosphamide 6atezolizumab 5Standard of Care 5Platinum 5Immunoglobulin G 5Ifosfamide 5Disulfides 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lung Neoplasms × Bupivacaine × Clear all
NCT06810375 2026-04-09

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

George Washington University

Phase 3 Recruiting
120 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡